Agilent (A) Form 144: Insider Plans Sale of 911 Shares

Agilent Technologies insider plans a small Rule 144 stock sale.

Rhea-AI Filing Summary

Agilent Technologies insider plans a small Rule 144 stock sale. The notice reports that Padraig Mcdonnell intends to sell 911 shares of Agilent common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 130,491.64. The filing notes 283,500,427 common shares outstanding. The shares to be sold were acquired via restricted stock vesting from the issuer on 11/15/2024 and 11/16/2024, in amounts of 523 and 388 shares as compensation.

Over the past three months, the same seller disposed of 2,000 Agilent common shares on 09/02/2025 for gross proceeds of 249,760.00 and 12,490 shares on 11/12/2025 for gross proceeds of 1,873,500.00. The signer represents that they do not know of any material adverse information about Agilent’s current or prospective operations that has not been publicly disclosed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Agilent (A) disclose in this Form 144 filing?

This Form 144 gives notice that Padraig Mcdonnell plans to sell 911 shares of Agilent common stock on the NYSE under Rule 144.

How many Agilent (A) shares are covered by the planned sale and what is their value?

The planned sale covers 911 common shares of Agilent, with an aggregate market value of 130,491.64 as stated in the filing.

How were the Agilent (A) shares in this Form 144 acquired?

The shares were acquired as restricted stock vesting from the issuer, with 523 shares vesting on 11/15/2024 and 388 shares vesting on 11/16/2024, both described as compensation.

What prior Agilent (A) stock sales by this insider are disclosed for the past 3 months?

The filing lists two prior sales by Padraig Mcdonnell: 2,000 common shares on 09/02/2025 for 249,760.00 in gross proceeds, and 12,490 common shares on 11/12/2025 for 1,873,500.00 in gross proceeds.

How many Agilent (A) shares are outstanding according to this Form 144?

The Form 144 states that 283,500,427 Agilent common shares were outstanding at the time referenced in the filing.

What representation does the seller make about Agilent (A) in this Form 144?

The seller represents that they do not know any material adverse information regarding Agilent’s current and prospective operations that has not been publicly disclosed.

Which broker is handling the planned Agilent (A) share sale under this Form 144?

The planned sale of 911 Agilent common shares is to be executed through Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 10:37 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001811108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AGILENT TECHNOLOGIES, INC.
SEC File Number	001-15405
Address of Issuer	5301 STEVENS CREEK BLVD SANTA CLARA CALIFORNIA 95051
Phone	(408) 345-8886
Name of Person for Whose Account the Securities are To Be Sold	MCDONNELL PADRAIG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	911	130491.64	283500427	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2024	Restricted Stock Vesting	Issuer			523	11/15/2024	Compensation
Common	11/16/2024	Restricted Stock Vesting	Issuer			388	11/16/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Padraig Mcdonnell 5301 Stevens Creek Blvd. Santa Clara CA 95051	Common	09/02/2025	2000	249760.00
Padraig Mcdonnell 5301 Stevens Creek Blvd. Santa Clara CA 95051	Common	11/12/2025	12490	1873500.00

144: Remarks and Signature

Remarks
Date of Notice	11/18/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Padraig Mcdonnell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)